REQUEST A DEMO
Total
USD $0.00
Search more companies

Smp-Implant OOO (Смп-Имплант ООО) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Smp-Implant OOO Profile Updated: October 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Smp-Implant OOO (Смп-Имплант ООО) is an enterprise in Russia, with the main office in Novosibirsk. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on October 26, 2011. It currently has a total number of 2 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 52.16% in 2024. Its’ total assets recorded a growth of 26.74%. The enterprise’s net profit margin increased by 0.2% in 2024.

Headquarters
Vatutina, 20/1
Novosibirsk; Novosibirsk Oblast; Postal Code: 630078

Contact Details: Purchase the Smp-Implant OOO (Смп-Имплант ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Smp-Implant OOO (Смп-Имплант ООО) report to view the information.
Registered Capital:
Purchase the Smp-Implant OOO (Смп-Имплант ООО) report to view the information.
Financial Auditors:
Purchase the Smp-Implant OOO (Смп-Имплант ООО) report to view the information.
Incorporation Date:
October 26, 2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
55%
Purchase this report to view the information.
45%
Company Performance
Financial values in the chart are available after Smp-Implant OOO (Смп-Имплант ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
52.16%
Total Operating Revenue
52.16%
Operating Profit
51.27%
Net Profit/Loss for the Period
53.22%
Total Assets
26.74%
Total Equity
32.04%
Operating Profit Margin
-0.2%
Net Profit Margin
0.2%
Return on Equity (ROE)
9.43%
Quick Ratio
0.05%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?